Inhibition of insulin-like growth factor I receptor expression in neuroblastoma cells induces the regression of established tumors in mice

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5432-5438

  Liu, Xiangdang ^a   Turbyville, Thomas ^a   Fritz, Anne ^a   Whitesell, Luke ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; LIPOCORTIN 5; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR REGRESSION;

ANIMALS; ANTISENSE ELEMENTS (GENETICS); APOPTOSIS; CELL DIVISION; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; FEMALE; GENE THERAPY; GENETIC VECTORS; INJECTIONS, INTRALESIONAL; MICE; MICE, INBRED A; MICE, INBRED BALB C; MICE, SCID; NEUROBLASTOMA; RECEPTOR, IGF TYPE 2; RNA, ANTISENSE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032401879     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Brodeur, G. M., and Castleberry, R. P. Neuroblastoma. In: P. A. Pizzo and D. G. Poplack (eds.), Principles and practice of pediatric oncology, Ed. 3, pp. 761-797. Philadelphia: Lippincott-Raven, 1997.
2. Baserga, R. The insulin-like growth factor 1 receptor: a key to tumor growth? Cancer Res., 55: 249-252, 1995.
3. LeRoith, D., Baserga, R., Helman, L., and Roberts, C. T., Jr. Insulin-like growth factors and cancer. Ann. Intern. Med., 122: 54-59, 1995.
4. Cianfarani, S., and Rossi, P. Neuroblastoma and insulin-like growth factor system. New insights and clinical perspectives. Eur. J. Pediatr., 156: 256-261, 1997.
5. Baker, J., Liu, J-P., Robertson, E. J., and Efstratiadis, A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell, 75: 73-82, 1993.
6. El-Badry, O., Romanus, J., Helman, L., Cooper, M., Rechler, M., and Israel, M. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J. Clin. Investig., 84: 829-839, 1989.
7. El-Badry, A., and Israel, M. Growth regulation of human neuroblastoma. In: C. Benz and T. L. Edison (eds.), Oncogenes and Tumor Suppressor Genes in Human Malignancies, pp. 105-128. Boston: Kluwer Academic, 1993.
8. Castle, V. P., Hanash, S. M., and Feldman, E. L. Insulin-like growth factor II (IGF-II) in the pathogenesis of human neuroblastoma. Am. J. Pathol., 147: 1790-1798, 1995.
9. El-Badry, O., Helman, L., Chatten, J., Steinberg, S., Evans, A., and Israel, M. Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J. Clin. Invest., 87: 648-657, 1991.
10. Singleton, J. R., Randolph, A. E., and Feldman, E. L. Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res., 56: 4522-4529, 1996.
11. Resnicoff, M., Sell, C., Rubini, M., Coppola, D., Ambrose, D., Baserga, R., and Rubin, R. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wildtype tumors. Cancer Res., 54: 2218-2222, 1994.
12. Ambrose, D., Resnicoff, M., Coppola, D., Sell, C., Miura, M., Jameson, S., Baserga, R., and Rubin, R. Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor. J. Cell. Physiol., 159: 92-100, 1994.
13. Neuenschwander, S., Roberts, C. T., Jr., and LeRoith, D. Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid. Endocrinology, 136: 4298-4303, 1995.
14. Bergmann, U., Funatomi, H., Yokoyama, M., Beger, H. G., and Korc, M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res., 55: 2007-2011, 1995.
15. Resnicoff, M., Coppola, D., Sell, C., Rubin, R., Ferrone, S., and Baserga, R. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res., 54: 4848-4850, 1994.
16. Shapiro, D. N., Jones, B. G., Shapiro, L. H., Dias, P., and Houghton, P. J. Antisense-mediated reduction in insulin-like growth factor 1 receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J. Clin. Invest., 94: 1235-1242, 1994.
17. Trojan, J., Johnson, T., Rudin, S., Ilan, J., Tykocinski, M., and Ilan, J. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor 1 RNA. Science (Washington DC), 259: 94-97, 1993.
18. Trojan, J., Blossey, B., Johnson, T., Rudin, S., Tykocinski, M., Ilan, J., and Ilan, J. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc. Natl. Acad. Sci. USA, 89: 4874-4878, 1992.
19. Arima, E., Byfield, J. E., Finklestein, J. Z., and Fonkalsrud, E. W. An experimental model for the therapy of mouse neuroblastoma. J. Pediatr. Surg., 8: 757-763, 1973.
20. Sell, C., Dumenil, G., Deveaud, C., Miura, M., Coppola, D., DeAngelis, T., Rubin, R., Efstratiadis, A., and Baserga, R. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol., 14: 3604-3612, 1994.
21. Whitesell, L., Rosolen, A., and Neckers, L. M. Episome-generated N-myc antisense RNA restricts the differentiation potential of primitive neuroectodermal cell lines. Mol. Cell. Biol., 11: 1360-1371, 1991.
22. Whitesell, L., Sutphin, P. D., Pulcini, E. J., Martinez, J. D., and Cook, P. H. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent. Mol. Cell. Biol., 18: 1517-1524, 1998.
23. Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods, 184: 39-51, 1995.
24. Cooper, M. J., Hutchins, G. M., Cohen, P. S., Helman, L. J., Mennie, R. J., and Israel, M. A. Human neuroblastoma tumors correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts. Cell Growth Differ., 1: 149-159, 1990.
25. Liu, J-P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor 1 (Igf-1) and type 1 IGF receptor (Igf1r). Cell, 75: 59-72, 1993.
26. Svrzic, D., and Schubert, D. Insulin-like growth factor I supports embryonic nerve cell survival. Biochem. Biophys. Res. Commun., 172: 54-60, 1990.
27. Bozyczko-Coyne, D., Glicksman, M. A., Pratner, J. E., McKenna. B., Connors, T., Friedman, C., Dasgupta, M., and Neff, N. IGF-I supports the survival and/or differentiation of multiple types of central nervous system neurons. Ann. NY Acad. Sci., 1992: 311-313, 1993.
28. Drago, J., Murphy, M., Carroll, S. M., Harvey, R. P., and Bartlett, P. F. Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I. Proc. Natl. Acad. Sci. USA, 88: 2199-2203, 1991.
29. Kalebic, T., Tsokos, M., and Helman, L. J. In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34. Cancer Res., 54: 5531-5534, 1994.
30. Rohlik, Q., Adams, D., Kull, F., Jr., and Jacobs, S. An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem. Biophys. Res. Commun., 149: 276-281, 1987.
31. Resnicoff, M., Burgaud, J-L., Rotman, H. L., Abraham, D., and Baserga, R. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res., 55: 3739-3741, 1995.
32. Rininsland, F., Johnson, T. R., Chernicky, C. L., Schulze, E., Burfeind, B., Ilan, J., and Ilan, J. Suppression of insulin-like growth factor I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells. Proc. Natl. Acad. Sci. USA, 94: 5854-5859, 1997.
33. Prager, D., Li, H. L., Asa, S., and Melmed, S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor-I receptor mutant. Proc. Natl. Acad. Sci. USA, 91: 2181-2185, 1994.
34. Hongo, A., Yumet, G., Resnicoff, M., Romano, G., O'Connor, R., and Baserga, R. Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor. Cancer Res., 58: 2477-2484, 1998.
35. Liu, Y., Lehar, S., Corvi, C., Payne, G., and O'Connor, R. Expression of the insulin-like growth factor 1 receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells. Cancer Res., 58: 570-576, 1998.
36. Neckers, L., Whitesell, L., Rosolen, A., and Geselowitz, D. Antisense inhibition of oncogene expression. Crit. Rev. Oncog., 3: 175-231, 1992.
37. Stein, C., and Cheng, Y-C. Antisense oligonucleotides as therapeutic agents-Is the bullet really magical? Science (Washington DC), 261: 1004-1012, 1993.
38. Kappel, C., Velez-Yanguas, M. C., Hirschfeld, S., and Helman, L. J. Human osteosarcoma cell lines are dependent on insulin-like growth factor for in vitro growth. Cancer Res., 54: 2803-2807, 1994.
39. O'Connor, R., Kauffmann-Zeh, A., Liu, Y., Lehar, S., Evan, G. I., Baserga, R., and Blattler, W. A. Identification of domains of the insulin-like growth factor receptor that are required for protection from apoptosis. Mol. Cell. Biol., 17: 427-435, 1997.
40. Kulik, G., Klippel, A., and Weber, M. J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase and Akt. Mol. Cell. Biol., 17: 1595-1606, 1997.
41. Rodriguez-Tarduchy, G., Collins, M. K. L., Garcia, I., and Lopez-Rivas, A. Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. J. Immunol., 149: 535-540, 1992.
42. Harrington, E. A., Bennett, M. R., Fanidi, A., and Evan, G. I. c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13: 3286-3295, 1994.
43. Sell, C., Baserga, R., and Rubin, R. Insulin-like growth factor 1 (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res., 55: 303-306, 1995.
44. Parrizas, M., Saltiel, A. R., and LeRoith, D. Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem., 272: 154-161, 1997.
45. Powis, G., Bonjouklian, R., Berggren, M. M., Gallegos, A., Abraham, R., Ashendel, C., Zalkow, L., Matter, W. F., Dodge, J., Grindey, G., and Vlahos, C. J. Wortmannin, a potent and selective inhibitor of phosphatidylinositol 3-kinase. Cancer Res., 54: 2419-2423, 1994.
46. Yang, J-P., and Huang, L. Direct gene transfer to mouse melanoma by intratumor injection of free DNA. Gene Ther., 3: 542-547, 1996.
47. Wang, Y., and Becker, D. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanoma blocks intratumoral angiogenesis and tumor growth. Nat. Med., 3: 887-893, 1997.
48. Plautz, G. E., Yang, Z., Wu, B., Gao, X., Huang, L., and Nabel, G. Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc. Natl. Acad. Sci. USA, 90: 4645-4649, 1993.
49. Nabel, G., Nabel, E., Yang, Z., Fox, B., Plautz, G., Gao, X., Huang, L., Shu, S., Gordon, D., and Chang, A. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA, 90: 11307-11311, 1993.
50. Fink, D. J., and Glorioso, J. C. Engineering herpes simplex virus vectors for gene transfer to neurons. Nat. Med., 3: 357-359, 1997.
51. Devitt, A., Moffatt, O. D., Raykundalia, C., Capra, J. D., Simmons, D. L., and Gregory, C. D. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature (Lond.), 392: 505-509, 1998.
52. Melcher, A., Todryk, S., Hardwick, N., Ford, M., Jacobson, M., and Vile, R. G. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med., 4: 581-587, 1998.
53. Evans, A., Gerson, J., and Schnaufer, L. Spontaneous regression of neuroblastoma. Natl. Cancer Inst. Monogr., 44: 49-54, 1976.
54. Brice, A. L., Cheetham, J. E., Bolton, V. N., Hill, N. C. W., and Schofield, P. N. Temporal changes in the expression of the insulin-like growth factor II gene associated with tissue maturation in the human fetus. Development (Camb.), 106: 543-554, 1989.